The U.S. Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry. This new avian flu vaccine, developed by New Jersey-based Zoetis, was approved last week after meeting safety and efficacy standards.

Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than 150 million birds have been affected in the US, causing egg prices to surge to all-time highs.

The company, Zoetis, said this license was granted on the “demonstration of safety, purity, and reasonable expectation of efficacy."

The U.S. Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry. This new avian flu vaccine, developed by New Jersey-based Zoetis, was approved last week after meeting safety and efficacy standards.

Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the impact of HPAI on poultry.

Zoetis, an animal health company, confirmed that the conditional vaccine was approved on Feb. 14. “When a new strain of HPAI was identified in the US in early 2022, our scientists immediately began work to update our previous avian influenza vaccine,

The vaccine from Zoetis, Avian Influenza Vaccine, H5N2 Subtype, Killed Virus, is for poultry and has been demonstrated to be safe, pure, and to have a reasonable expectation of efficacy

Zoetis (ZTS) announced that the U.S. Department of Agriculture, Center for Veterinary Biologics, has issued the company a conditional license

Zoetis said the U.S. Department of Agriculture's Center for Veterinary Biologics issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labeled for use in chickens,

Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype,

The New Jersey-based drugmaker secured a conditional license to protect chickens with its H5N2 subtype vaccine.

In a press release, global animal health company Zoetis announced that it received conditional approval from the USDA for a vaccine it developed for bird flu.